RankAlpha logo
Back to Rankings

ALMS

AlumisD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
ALMS vs peer average
52/100
ALMS vs. peer average (D vs. D)
Grade spread
B 1 · C 1 · D 2 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ARQT is the first available peer comparator.

Dermatology-biotech peer with more commercial footing; useful for framing psoriasis launch expectations.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerARQTArcutis Biotherapeutics
ALMS
Alumis
ARQT
Arcutis Biotherapeutics
Grade
D
B
Momentum
1
16
Value
41
57
Sentiment
56
81
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs ARQT

ALMS / ARQT
Grade Position
In line
ALMS vs. peer average (D vs. D)
52/100
Momentum
1
ARQT
Value
41
ARQT
Sentiment
56
ARQT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ALMS
1
ARQT
ARQT
B
80/100
-2
2
CLDX
CLDX
D
40/100
Even
3
IOVA
IOVA
F
20/100
+1
4
NAMS
NewAmsterdam Pharma Company NV Common
F
20/100
+1
5
MBX
MBX Biosciences Inc Common
F
20/100
+1
ARQT is the first peer returned for this comparison set.